Alterations in behavior, amyloid β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease

FASEB Journal

Volumn 16, Issue 8, 2002, Pages 805-813

  Hwang, Dae Y ^a   Chae, Kab R ^a   Kang, Tae S ^a   Hwang, Jin H ^a   Lim, Chae H ^b   Kang, Hyun K ^c   Goo, Jun S ^a   Lee, M I R ^c   Lim, Hwa J ^a   Min, Sae H ^a   Cho, Jun Y ^a   Hong, Jin T ^b   Song, Chi W ^b   Paik, Sang G ^a   Cho, Jung S ^a   Kim, Yong K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Chungbuk National University   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

A 42; AD; Amyloid precursor protein; PS2

Indexed keywords

AMYLOID BETA 42 PROTEIN; AMYLOID BETA PROTEIN; ANTIBODY; CASPASE 3; CYCLOOXYGENASE 2; PRESENILIN 2; UNCLASSIFIED DRUG; WATER;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; DOT HYBRIDIZATION; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; STAINING; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CASPASE 3; CASPASES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; PRESENILIN-2; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECOMBINANT FUSION PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0036275638     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0732com     Document Type: Article

References (35)

1. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
2. Segregation of a missense mutation in the amyloid precursor protein gene with familiar Alzheimer's disease
3. Cloning of a gene bearing missense mutation in early onset familial Alzheimer's disease
4. Familial Alzheimer's disease in kindreds with missense mutation in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
5. Gene dose apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
6. Apolipoprotein E and Alzheimer's disease
7. Familial Alzheimer's chromosome 14 mutations
8. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene
9. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
10. Alzheimer-associated presenilin 1 and 2: Neuronal expression in brain and localization to intracellular membrane in mammalian cells
11. Expression and analysis of presenilin 1 in a human neuronal system: Localization in cell bodies and dendrites
12. The Alzheimer's disease-associated presenilins are differentially within the endoplasmic reticulum
13. Increase apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N14II)
14. Endoproteolytic cleavage and proteosomal degradation of presenilin-2 in transfected cell
15. Alternative cleavage of Alzheimer-associated presenilin-2 during apoptosis
16. Presenilins are processed by caspase-type proteases
17. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease and APP mutations linked to familial Alzheimer's disease
18. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
19. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
20. Ageing renders the brain vulnerable to amyloid β-protein neurotoxicity
21. RAGE and amyloid-β-peptide neurotoxicity in Alzheimer's disease
22. Binding of beta amyloid to the p75 neurotrophin receptor induces apoptosis
23. Transgenic mice expressing β-galactosidase in mature neuron under neuron-specific enolase promoter control
24. Identification of caspases that cleave presenilin-1 and presenilin-2-five presenilin-1 mutation do not alter the sensitivity of PS1 to caspases
25. Mutant preselin 2 transgenic mouse: Effect on an age-dependent increase of amyloid β-protein 42 in the brain
26. Mutant presenilin 2 transgenic mice. A large increase in the levels of Aβ-42 presumably associated with the low density membrane domain that contains decreased levels of glycero-phospholipids and sphingomyelin
27. The topographical and neuroanatomical distribution of neurofibrillary tangles and neurotic plaques in the cerebral cortex of patient with Alzheimer's disease
28. Differences in the pattern of hippocampal neuron loss in normal ageing and Alzheimer's disease
29. Reorganization of cingulate cortex I Alzheimer's disease: Neuron loss, neuritic plaques, and muscarinic receptor binding
30. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation
31. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease
32. Distribution of the cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
33. Induction of cyclooxygenase-2 in brains of patients with Down's syndrome and dementia of Alzheimer type: Specific localization in affected neurons and axons
34. The preselin 2 mutation (N141I) linked to familiar Alzheimer disease (Volga German Families) increases the secretion of amyloid β-protein ending at the 42nd (or 43rd) residue
35. Progress toward valid transgenic models for Alzheimer's disease